Healthcare reformers hold pharma investments

Almost 30 key lawmakers helping draft landmark healthcare legislation have financial holdings in the industry totaling nearly $11 million, including sizable stock investments in the likes of Eli Lilly, Bristol-Myers Squibb, and Merck. The investments aren't against the rules, and in some cases represent a small percentage of the Congressional reps' net worth, but critics worry that personal finances might influence their reform efforts. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.